Development and Evaluation of Curcumin-Loaded Mucoadhesive Buccal Films Using Green Deep Eutectic Solvents via Design of Experiments

<b>Background/Objectives:</b> This study aimed to develop and formulation-design curcumin-loaded buccal films using a green deep eutectic solvent (DES) to improve drug solubility and support localized mucosal delivery, with the help of a Design of Experiments (DoE) approach. <b>Methods:</b> Various DESs with different components and molar ratios were prepared, characterized, and the optimal DES was selected. Curcumin-loaded buccal films were prepared by solvent casting, employing the optimal DES as the solvent system. A three-factor and five-level central composite design was applied to <b>s</b>ystematically investigate the amounts of HPMC K100, Kollicoat<sup>®</sup> IR, and DES in buccal films, and mucoadhesive strength, elongation (%), swelling index, swelling time, and thickness were identified as critical responses. Based on these responses, characterization, in vitro release, ex vivo permeation, and in vitro biological activity studies were performed on the model-predicted optimal formulations. <b>Results:</b> Choline chloride: propylene glycol (1:4 molar ratio) was selected as the optimal DES due to its viscosity, pH, organoleptic properties, and the highest curcumin solubility (11.90 ± 0.15 mg/mL). While DES increased curcumin solubility, buccal films were successfully obtained. Six formulations identified through model-based DoE optimization were advanced to detailed experimental evaluation. The drug release exhibited sustained curcumin release profiles over 24 h, and ex vivo studies showed <2% mucosal permeation. The lead formulations demonstrated in vitro cell compatibility, anti-inflammatory and antioxidant activities, and enhanced wound-healing-related bioactivity. <b>Conclusions:</b> Curcumin-loaded buccal films containing DES and developed using a DoE-guided formulation strategy successfully demonstrated the acceptable formulation properties and screening-level in vitro biological activities, offering a promising formulation platform for localized buccal delivery applications.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2026-02-15
DOI
https://doi.org/10.3390/pharmaceutics18020245
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and Evaluation of Curcumin-Loaded Mucoadhesive Buccal Films Using Green Deep Eutectic Solvents via Design of Experiments

Hande Si̇pahi̇, Melike Sevim, Muhammet Davut Arpa, Kübra Kolci et al.
Pharmaceutics
Advanced Drug Delivery Systems
article

Development and Evaluation of Curcumin-Loaded Mucoadhesive Buccal Films Using Green Deep Eutectic Solvents via Design of Experiments

Hande Si̇pahi̇, Melike Sevim, Muhammet Davut Arpa, Kübra Kolci, Neslihan Üstündağ Okur
article en

Abstract

<b>Background/Objectives:</b> This study aimed to develop and formulation-design curcumin-loaded buccal films using a green deep eutectic solvent (DES) to improve drug solubility and support localized mucosal delivery, with the help of a Design of Experiments (DoE) approach. <b>Methods:</b> Various DESs with different components and molar ratios were prepared, characterized, and the optimal DES was selected. Curcumin-loaded buccal films were prepared by solvent casting, employing the optimal DES as the solvent system. A three-factor and five-level central composite design was applied to <b>s</b>ystematically investigate the amounts of HPMC K100, Kollicoat<sup>®</sup> IR, and DES in buccal films, and mucoadhesive strength, elongation (%), swelling index, swelling time, and thickness were identified as critical responses. Based on these responses, characterization, in vitro release, ex vivo permeation, and in vitro biological activity studies were performed on the model-predicted optimal formulations. <b>Results:</b> Choline chloride: propylene glycol (1:4 molar ratio) was selected as the optimal DES due to its viscosity, pH, organoleptic properties, and the highest curcumin solubility (11.90 ± 0.15 mg/mL). While DES increased curcumin solubility, buccal films were successfully obtained. Six formulations identified through model-based DoE optimization were advanced to detailed experimental evaluation. The drug release exhibited sustained curcumin release profiles over 24 h, and ex vivo studies showed <2% mucosal permeation. The lead formulations demonstrated in vitro cell compatibility, anti-inflammatory and antioxidant activities, and enhanced wound-healing-related bioactivity. <b>Conclusions:</b> Curcumin-loaded buccal films containing DES and developed using a DoE-guided formulation strategy successfully demonstrated the acceptable formulation properties and screening-level in vitro biological activities, offering a promising formulation platform for localized buccal delivery applications.

PharmaceuticsVol. 18(2)
Yeditepe University (TR), Istanbul Medipol University (TR), Sağlık Bilimleri Üniversitesi (TR), Kent Hastanesi (TR), University of Health Sciences Antigua (AG)
Openalex Percentile: Top 53%
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.